<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a case of <z:e sem="disease" ids="C0162739" disease_type="Disease or Syndrome" abbrv="HELLP">HELLP syndrome</z:e>, multiple liver infarctions, and intrauterine fetal <z:hpo ids='HP_0011420'>death</z:hpo> in a woman in the 17th week of pregnancy with SLE and APS who had been in remission on a regimen of low-dose <z:chebi fb="2" ids="8378">prednisolone</z:chebi> and aspirin </plain></SENT>
<SENT sid="1" pm="."><plain>An increase in the dosage of <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> together with intravenous <z:chebi fb="5" ids="28304">heparin</z:chebi> infusion led to improvement of the clinical symptoms, laboratory parameters, and multifocal low-density liver lesions detected by computed tomography </plain></SENT>
<SENT sid="2" pm="."><plain>Early <z:hpo ids='HP_0003674'>onset</z:hpo> and signs of severe organ involvement are the characteristic features of <z:e sem="disease" ids="C0162739" disease_type="Disease or Syndrome" abbrv="HELLP">HELLP syndrome</z:e> associated with APS, and patients that are at risk should be followed up carefully </plain></SENT>
</text></document>